Sartorius Aktiengesellschaft (0NIQ.L)
EUR 178.4
(1.02%)
EUR 178.4
(1.02%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 3.00 EUR | -69.73% |
| 2022 | 9.91 EUR | 112.66% |
| 2021 | 4.66 EUR | 51.79% |
| 2020 | 3.07 EUR | 34.06% |
| 2019 | 2.29 EUR | 10.63% |
| 2018 | 2.07 EUR | 23.21% |
| 2017 | 1.68 EUR | 11.26% |
| 2016 | 1.51 EUR | 20.8% |
| 2015 | 1.25 EUR | 95.31% |
| 2014 | 0.64 EUR | -8.57% |
| 2013 | 0.70 EUR | -1.41% |
| 2012 | 0.71 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 0.54 EUR | 350.0% |
| 2024 Q2 | 0.35 EUR | -35.19% |
| 2024 Q3 | 0.21 EUR | -40.0% |
| 2023 FY | - EUR | -69.73% |
| 2023 Q4 | 0.12 EUR | -7.69% |
| 2023 Q2 | 1.39 EUR | 2.21% |
| 2023 Q1 | 1.36 EUR | -39.01% |
| 2023 Q3 | 0.13 EUR | -90.65% |
| 2022 Q2 | 2.42 EUR | -19.6% |
| 2022 Q1 | 3.01 EUR | 785.29% |
| 2022 FY | - EUR | 112.66% |
| 2022 Q3 | 2.25 EUR | -7.02% |
| 2022 Q4 | 2.23 EUR | -0.89% |
| 2021 Q2 | 1.58 EUR | 0.0% |
| 2021 Q4 | 0.34 EUR | -77.92% |
| 2021 FY | - EUR | 51.79% |
| 2021 Q1 | - EUR | -100.0% |
| 2021 Q3 | 1.54 EUR | -2.53% |
| 2020 Q1 | - EUR | -100.0% |
| 2020 Q2 | - EUR | 0.0% |
| 2020 Q3 | - EUR | 0.0% |
| 2020 Q4 | 0.94 EUR | 0.0% |
| 2020 FY | - EUR | 34.06% |
| 2019 Q3 | - EUR | 0.0% |
| 2019 Q1 | - EUR | -100.0% |
| 2019 FY | - EUR | 10.63% |
| 2019 Q4 | 0.52 EUR | 0.0% |
| 2019 Q2 | - EUR | 0.0% |
| 2018 Q2 | - EUR | 0.0% |
| 2018 FY | - EUR | 23.21% |
| 2018 Q4 | 0.73 EUR | 0.0% |
| 2018 Q1 | - EUR | -100.0% |
| 2018 Q3 | - EUR | 0.0% |
| 2017 FY | - EUR | 11.26% |
| 2017 Q1 | - EUR | -100.0% |
| 2017 Q2 | - EUR | 0.0% |
| 2017 Q3 | - EUR | 0.0% |
| 2017 Q4 | 0.68 EUR | 0.0% |
| 2016 Q2 | - EUR | 0.0% |
| 2016 FY | - EUR | 20.8% |
| 2016 Q4 | 0.33 EUR | 0.0% |
| 2016 Q3 | - EUR | 0.0% |
| 2016 Q1 | - EUR | -100.0% |
| 2015 Q3 | - EUR | 0.0% |
| 2015 FY | - EUR | 95.31% |
| 2015 Q2 | - EUR | 0.0% |
| 2015 Q1 | - EUR | -100.0% |
| 2015 Q4 | 0.27 EUR | 0.0% |
| 2014 Q2 | - EUR | 0.0% |
| 2014 Q1 | - EUR | 0.0% |
| 2014 Q3 | - EUR | 0.0% |
| 2014 Q4 | 0.14 EUR | 0.0% |
| 2014 FY | - EUR | -8.57% |
| 2013 Q2 | - EUR | 0.0% |
| 2013 Q1 | - EUR | -100.0% |
| 2013 Q3 | - EUR | 0.0% |
| 2013 Q4 | - EUR | 0.0% |
| 2013 FY | - EUR | -1.41% |
| 2012 FY | - EUR | 0.0% |
| 2012 Q4 | 0.17 EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Cegedim SA | -0.54 EUR | 655.556% |
| Guerbet SA | 1.90 EUR | -57.895% |
| Nexus AG | 1.39 EUR | -115.827% |
| Bastide Le Confort Médical SA | -0.12 EUR | 2600.0% |
| Revenio Group Oyj | 0.72 EUR | -316.667% |
| Drägerwerk AG & Co. KGaA | 5.89 EUR | 49.066% |
| LNA Santé SA | 2.29 EUR | -31.004% |
| Siemens Healthineers AG | 1.74 EUR | -72.414% |
| Medios AG | 0.79 EUR | -279.747% |
| Equasens Société anonyme | 3.13 EUR | 4.153% |
| Stratec SE | 1.07 EUR | -180.374% |